Gavi’s health system strengthening (HSS) support is regularly evaluated to provide valuable insights into the HSS programme
Gavi has provided HSS support to countries since 2007. The main purpose is to use innovative solutions to address health system barriers that hamper access to immunisation. Our HSS support has evolved over the years, partly as a result of evidence gathered through evaluations.
In 2013, we initiated the full country evaluations project which includes assessments of HSS support in four countries: Bangladesh, Uganda, Mozambique and Zambia.
Since 2014, countries are required to include a plan for an end-of-grant evaluation in their HSS proposals. They are also strongly encouraged to plan for a mid-term evaluation.
To provide increased learning and accountability on HSS grants, Gavi commissioned an HSS meta-review in 2015. This includes the 14 country HSS evaluations completed in the 2013–2015 period, which are listed below. The findings will provide valuable insights to inform future HSS grants as well as other types of Gavi support.
The objectives of the HSS meta-review are to:
- synthesise findings regarding Gavi HSS grants (including relevance, implementation, effectiveness, efficiency, results and sustainability) and assess their robustness;
- assess the extent to which Gavi HSS grants have complemented other resources at the country level (if information is available);
- assess the extent to which challenges identified have been addressed through modifications to Gavi’s approach to HSS over time and make recommendations for additional improvements; and
- help countries and the Vaccine Alliance in their ongoing efforts to improve the HSS support window, with particular focus on implementation.
HSS evaluation reports included in the meta-review: